RS20050344A - Treatment for hemorrhagic shock - Google Patents
Treatment for hemorrhagic shockInfo
- Publication number
- RS20050344A RS20050344A YUP-2005/0344A YUP20050344A RS20050344A RS 20050344 A RS20050344 A RS 20050344A YU P20050344 A YUP20050344 A YU P20050344A RS 20050344 A RS20050344 A RS 20050344A
- Authority
- RS
- Serbia
- Prior art keywords
- treatment
- hemorrhagic shock
- patient
- risk
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
Abstract
Predmetni pronalazak se odnosi na postupke i preparate za lečenje pacijenata koji boluju od ili koji poseduju rizik za nastanak hemoragijskog šoka. Tretman obuhvata primenu kod pacijenta farmaceutskog preparata koji sadrži ugljen monoksid.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42480402P | 2002-11-07 | 2002-11-07 | |
PCT/US2003/030956 WO2004043341A2 (en) | 2002-11-07 | 2003-09-30 | Treatment for hemorrhagic shock |
Publications (1)
Publication Number | Publication Date |
---|---|
RS20050344A true RS20050344A (en) | 2007-11-15 |
Family
ID=32312877
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YUP-2005/0344A RS20050344A (en) | 2002-11-07 | 2003-09-30 | Treatment for hemorrhagic shock |
Country Status (13)
Country | Link |
---|---|
US (1) | US20040228930A1 (sr) |
EP (1) | EP1558084A4 (sr) |
JP (1) | JP2006514621A (sr) |
CN (1) | CN1719975A (sr) |
AU (1) | AU2003283982A1 (sr) |
CA (1) | CA2504604A1 (sr) |
EA (1) | EA200500782A1 (sr) |
HR (1) | HRP20050389A2 (sr) |
MX (1) | MXPA05004924A (sr) |
NO (1) | NO20052348L (sr) |
PL (1) | PL377733A1 (sr) |
RS (1) | RS20050344A (sr) |
WO (1) | WO2004043341A2 (sr) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7678390B2 (en) * | 1999-04-01 | 2010-03-16 | Yale University | Carbon monoxide as a biomarker and therapeutic agent |
GB0111872D0 (en) | 2001-05-15 | 2001-07-04 | Northwick Park Inst For Medica | Therapeutic agents and methods |
SK15942003A3 (sk) * | 2001-06-21 | 2004-08-03 | Beth Israel Deaconess Medical Center, Inc. | Farmaceutická kompozícia s obsahom oxidu uhoľnatého zlepšujúca prežívanie alebo funkciu orgánov po transplantácii |
US7968605B2 (en) * | 2002-02-04 | 2011-06-28 | ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
EP2042181A1 (en) | 2002-02-04 | 2009-04-01 | ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. | Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases |
US20080026984A1 (en) * | 2002-02-04 | 2008-01-31 | Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
AU2003216368B2 (en) | 2002-04-15 | 2007-08-09 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Methods of treating ileus |
AU2003223562B2 (en) * | 2002-04-15 | 2009-04-09 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Methods of treating necrotizing enterocolitis |
US8097585B2 (en) | 2002-04-15 | 2012-01-17 | Beth Israel Deaconess Medical Center, Inc. | Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation |
US20040052866A1 (en) | 2002-05-17 | 2004-03-18 | Otterbein Leo E. | Methods of treating hepatitis |
CA2487413A1 (en) * | 2002-06-05 | 2003-12-18 | Yale University | Methods of treating angiogenesis, tumor growth, and metastasis |
PL375161A1 (en) * | 2002-06-21 | 2005-11-28 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
GB2395432B (en) * | 2002-11-20 | 2005-09-14 | Northwick Park Inst For Medica | Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs |
WO2005041655A1 (en) | 2003-10-22 | 2005-05-12 | Fred Hutchinson Cancer Research Center | Methods, compositions and devices for inducing stasis in cells, tissues, organs, and organisms |
US7523752B2 (en) | 2005-09-21 | 2009-04-28 | Ino Therapeutics, Llc | System and method of administering a pharmaceutical gas to a patient |
US8893717B2 (en) | 2005-09-21 | 2014-11-25 | Ino Therapeutics Llc | Systems and methods of administering a pharmaceutical gas to a patient |
CA2624467A1 (en) * | 2005-09-30 | 2007-04-12 | Ovation Pharmaceuticals, Inc. | Method of treating pancreatitis |
JPWO2007073005A1 (ja) * | 2005-12-22 | 2009-06-04 | 学校法人慶應義塾 | メチル基転移反応調節物質 |
GB0601394D0 (en) | 2006-01-24 | 2006-03-01 | Hemocorm Ltd | Therapeutic delivery of carbon monoxide |
JP5020525B2 (ja) * | 2006-03-30 | 2012-09-05 | 財団法人生産開発科学研究所 | 配位子置換型輸液製剤 |
US7766857B2 (en) * | 2006-08-21 | 2010-08-03 | General Electric Company | Non-invasive determination of cardiac output, gas exchange and arterial blood gas concentration |
WO2008063868A2 (en) * | 2006-11-07 | 2008-05-29 | The General Hospital Corporation | Attenuation of vasoactive oxygen carrier-induced vasoconstriction |
WO2008069688A2 (en) * | 2006-12-06 | 2008-06-12 | Alfama - Investigação E Desenvolvimento De Produtos Farmacêuticos Lda | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
CA2754549A1 (en) | 2009-03-05 | 2010-09-10 | The Uab Research Foundation | Enhancing coagulation or reducing fibrinolysis |
CN103491783A (zh) | 2011-01-14 | 2014-01-01 | 洛杉矶儿童医院 | 用于治疗包括镰状细胞疾病的疾病的一氧化碳溶液 |
PT2699242T (pt) | 2011-04-19 | 2018-01-22 | Alfama Inc | Moléculas de libertação de monóxido de carbono e utilizações das mesmas |
ES2628634T3 (es) | 2011-07-21 | 2017-08-03 | Alfama, Inc. | Moléculas liberadoras de monóxido de carbono-rutenio y usos de las mismas |
WO2013022946A1 (en) | 2011-08-09 | 2013-02-14 | Beth Israel Deaconess Medical Center, Inc. | Methods of treating dna damage |
WO2020198604A1 (en) * | 2019-03-28 | 2020-10-01 | United States Government As Represented By The Department Of Veterans Affairs | Compositions and methods of treating and preventing systemic complications of acute illness |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4053590A (en) * | 1975-02-27 | 1977-10-11 | Alza Corporation | Compositions of matter comprising macromolecular hemoglobin |
US4264739A (en) * | 1979-01-05 | 1981-04-28 | Merck & Co., Inc. | Sparger for cell culture system |
US5240912A (en) * | 1983-05-09 | 1993-08-31 | Todaro George J | Transforming growth factor (TGF) peptides |
US5084380A (en) * | 1985-01-29 | 1992-01-28 | Applied Biotechnology | Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins |
US5449665A (en) * | 1985-09-24 | 1995-09-12 | Item Development Aktiebolag | Continuous intravenous infusion of adenosine to human patients undergoing percutaneous transluminal angioplasty |
DE3739650C1 (de) * | 1987-11-23 | 1989-05-24 | Immuno Ag | Fermenter zum Zuechten von Zellkulturen |
US5180366A (en) * | 1990-10-10 | 1993-01-19 | Woods W T | Apparatus and method for angioplasty and for preventing re-stenosis |
US5792325A (en) * | 1990-11-15 | 1998-08-11 | Richardson, Jr.; William H. | Electric arc material processing system |
US5293875A (en) * | 1992-06-16 | 1994-03-15 | Natus Medical Incorporated | In-vivo measurement of end-tidal carbon monoxide concentration apparatus and methods |
BR9405798A (pt) * | 1993-02-22 | 1995-12-12 | Vivorx Pharmaceuticals Inc | Métodos para liberação in vivo de material biológico e composições úteis dos mesmos |
ES2062943B1 (es) * | 1993-03-23 | 1995-11-16 | Uriach & Cia Sa J | Nuevos derivados de la (2-metil-3-piridil) cianometilpiperazinas. |
US5763431A (en) * | 1993-08-20 | 1998-06-09 | Jackson; Meyer B. | Method for regulating neuropeptide hormone secretion |
US5504090A (en) * | 1994-03-30 | 1996-04-02 | Trustees Of The University Of Pennsylvania | Compositions and methods for the prevention and treatment of ischemia-reperfusion organ injury |
DE4421433C1 (de) * | 1994-06-18 | 1995-06-08 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit Wirkstoffen, die Kohlenmonoxid-Quellen darstellen, Verfahren zu seiner Herstellung und seine Verwendung |
US5476764A (en) * | 1994-09-16 | 1995-12-19 | The Regents Of The University Of California | Method using CO for extending the useful shelf-life of refrigerated red blood cells |
US6066333A (en) * | 1994-09-22 | 2000-05-23 | William Harvey Research Limited | Pharmaceutical control of inflammation |
US5664563A (en) * | 1994-12-09 | 1997-09-09 | Cardiopulmonary Corporation | Pneumatic system |
US5914316A (en) * | 1994-12-16 | 1999-06-22 | Washington University | Method of inhibiting intimal hyperplasia |
US5712293A (en) * | 1995-06-07 | 1998-01-27 | Sepracor, Inc. | Methods for treating gastro-esophageal reflux disease and other disorders associated with the digestive tract using optically pure (-) norcisapride |
FR2735382B1 (fr) * | 1995-06-15 | 1997-07-25 | Air Liquide | Installation de production de monoxyde de carbone incorporant une unite de separation cryogenique |
US5731326A (en) * | 1995-06-30 | 1998-03-24 | Zymogenetics, Inc. | PDGF antagonists II |
JP2000510448A (ja) * | 1996-04-05 | 2000-08-15 | ザ ジェネラル ホスピタル コーポレーション | 異常ヘモグロビン症の治療 |
US6069132A (en) * | 1996-08-14 | 2000-05-30 | Revanker; Ganapathi R. | Phosphazole compounds |
US8128963B2 (en) * | 1996-09-27 | 2012-03-06 | The Trustees Of Columbia University In The City Of New York | Methods for treating ischemic disorders using carbon monoxide |
US6316403B1 (en) * | 1996-09-27 | 2001-11-13 | The Trustees Of Columbia University In The City Of New York | Methods for treating an ischemic disorder and improving stroke outcome |
DK0951292T3 (da) * | 1996-09-27 | 2007-08-13 | Univ Columbia | Behandling af en iskæmisk lidelse og forbedring af udfald af slagtilfælde |
US6203991B1 (en) * | 1998-08-21 | 2001-03-20 | The Regents Of The University Of Michigan | Inhibition of smooth muscle cell migration by heme oxygenase I |
US7678390B2 (en) * | 1999-04-01 | 2010-03-16 | Yale University | Carbon monoxide as a biomarker and therapeutic agent |
US20050250688A1 (en) * | 1999-04-01 | 2005-11-10 | The Trustees Of Columbia University In The City Of New York | Methods for treating an ischemic disorder and improving stroke outcome |
US7632803B2 (en) * | 1999-10-01 | 2009-12-15 | Dmi Life Sciences, Inc. | Metal-binding compounds and uses therefor |
FR2812197B1 (fr) * | 2000-07-27 | 2003-01-03 | Air Liquide Sante Int | Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches |
FR2816212A1 (fr) * | 2000-11-03 | 2002-05-10 | Air Liquide Sante Int | Utilisation de monoxyde de carbone (co) dans le traitement des inflammations du systeme cardiovasculaire |
WO2002080859A2 (en) * | 2001-03-20 | 2002-10-17 | Glaxo Group Limited | Inhalation drug combinations |
US20030068387A1 (en) * | 2001-03-30 | 2003-04-10 | Roland Buelow | Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders |
GB0111872D0 (en) * | 2001-05-15 | 2001-07-04 | Northwick Park Inst For Medica | Therapeutic agents and methods |
US7122027B2 (en) * | 2001-05-25 | 2006-10-17 | Medtronic, Inc. | Implantable medical device with controllable gaseous agent release system |
SK15942003A3 (sk) * | 2001-06-21 | 2004-08-03 | Beth Israel Deaconess Medical Center, Inc. | Farmaceutická kompozícia s obsahom oxidu uhoľnatého zlepšujúca prežívanie alebo funkciu orgánov po transplantácii |
EP2042181A1 (en) * | 2002-02-04 | 2009-04-01 | ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. | Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases |
JP2005525848A (ja) * | 2002-02-13 | 2005-09-02 | ベス イスラエル ディコネス メディカル センター | 血管疾患の治療方法 |
AU2003223562B2 (en) * | 2002-04-15 | 2009-04-09 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Methods of treating necrotizing enterocolitis |
US8097585B2 (en) * | 2002-04-15 | 2012-01-17 | Beth Israel Deaconess Medical Center, Inc. | Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation |
AU2003216368B2 (en) * | 2002-04-15 | 2007-08-09 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Methods of treating ileus |
US20040052866A1 (en) * | 2002-05-17 | 2004-03-18 | Otterbein Leo E. | Methods of treating hepatitis |
CA2487413A1 (en) * | 2002-06-05 | 2003-12-18 | Yale University | Methods of treating angiogenesis, tumor growth, and metastasis |
PL375161A1 (en) * | 2002-06-21 | 2005-11-28 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
-
2003
- 2003-09-30 US US10/676,280 patent/US20040228930A1/en not_active Abandoned
- 2003-09-30 JP JP2004551490A patent/JP2006514621A/ja not_active Withdrawn
- 2003-09-30 PL PL377733A patent/PL377733A1/pl unknown
- 2003-09-30 RS YUP-2005/0344A patent/RS20050344A/sr unknown
- 2003-09-30 EP EP03776209A patent/EP1558084A4/en not_active Withdrawn
- 2003-09-30 EA EA200500782A patent/EA200500782A1/ru unknown
- 2003-09-30 WO PCT/US2003/030956 patent/WO2004043341A2/en active Application Filing
- 2003-09-30 CN CNA038257726A patent/CN1719975A/zh active Pending
- 2003-09-30 MX MXPA05004924A patent/MXPA05004924A/es unknown
- 2003-09-30 CA CA002504604A patent/CA2504604A1/en not_active Abandoned
- 2003-09-30 AU AU2003283982A patent/AU2003283982A1/en not_active Abandoned
-
2005
- 2005-05-02 HR HR20050389A patent/HRP20050389A2/hr not_active Application Discontinuation
- 2005-05-12 NO NO20052348A patent/NO20052348L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MXPA05004924A (es) | 2005-08-18 |
HRP20050389A2 (en) | 2005-08-31 |
EA200500782A1 (ru) | 2005-10-27 |
CA2504604A1 (en) | 2004-05-27 |
JP2006514621A (ja) | 2006-05-11 |
EP1558084A2 (en) | 2005-08-03 |
CN1719975A (zh) | 2006-01-11 |
WO2004043341A2 (en) | 2004-05-27 |
NO20052348D0 (no) | 2005-05-12 |
NO20052348L (no) | 2005-08-02 |
WO2004043341A3 (en) | 2004-07-15 |
AU2003283982A1 (en) | 2004-06-03 |
US20040228930A1 (en) | 2004-11-18 |
EP1558084A4 (en) | 2008-04-30 |
PL377733A1 (pl) | 2006-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS20050344A (en) | Treatment for hemorrhagic shock | |
UA86344C2 (ru) | Способ лечения сосудистых заболеваний | |
EP1558220A4 (en) | ORAL COMPOSITIONS FOR THE TREATMENT OF DISEASES | |
UA85041C2 (ru) | Способ лечения кишечной непроходимости | |
YU20050003A (sh) | Postupak i uređaj za davanje co | |
NO20045056L (no) | Fremgangsmater for behandling av hepatitt | |
MXPA05008649A (es) | Terapia de combinacion para el tratamiento de desordenes inmunoinflamatorios. | |
MX2010002498A (es) | Metodos para tratar o prevenir la infeccion del tracto respiratorio que comprende la administracion de colecalciferol. | |
UA86570C2 (ru) | Способ лечения некротизирующего энтероколита | |
MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
IL168308A (en) | Compositions containing roflumilast and formoterol | |
TW200719903A (en) | Compositions for the treatment of neoplasms | |
WO2004073615A8 (en) | Deazaflavin compounds and methods of use thereof | |
IL168307A (en) | Compositions containing roflumilast and (r,r)-formoterol | |
TW200501958A (en) | A therapeutic agent for treating a behavioral disorder | |
TW200519078A (en) | 2-alkylidene-19-nor-vitamin d derivatives for the treatment of a second hip fracture |